Literature DB >> 17331988

Nitroxyl increases force development in rat cardiac muscle.

Tieying Dai1, Ye Tian, Carlo Gabriele Tocchetti, Tatsuo Katori, Anne M Murphy, David A Kass, Nazareno Paolocci, Wei Dong Gao.   

Abstract

Donors of nitroxyl (HNO), the reduced congener of nitric oxide (NO), exert positive cardiac inotropy/lusitropy in vivo and in vitro, due in part to their enhancement of Ca(2+) cycling into and out of the sarcoplasmic reticulum. Here we tested whether the cardiac action of HNO further involves changes in myofilament-calcium interaction. Intact rat trabeculae from the right ventricle were mounted between a force transducer and a motor arm, superfused with Krebs-Henseleit (K-H) solution (pH 7.4, room temperature) and loaded iontophoretically with fura-2 to determine [Ca(2+)](i). Sarcomere length was set at 2.2-2.3 microm. HNO donated by Angeli's salt (AS; Na(2)N(2)O(3)) dose-dependently increased both twitch force and [Ca(2+)](i) transients (from 50 to 1000 microm). Force increased more than [Ca(2+)](i) transients, especially at higher doses (332 +/- 33% versus 221 +/- 27%, P < 0.01 at 1000 microm). AS/HNO (250 microm) increased developed force without changing Ca(2+) transients at any given [Ca(2+)](o) (0.5-2.0 mm). During steady-state activation, AS/HNO (250 microm) increased maximal Ca(2+)-activated force (F(max), 106.8 +/- 4.3 versus 86.7 +/- 4.2 mN mm(-2), n = 7-8, P < 0.01) without affecting Ca(2+) required for 50% activation (Ca(50), 0.44 +/- 0.04 versus 0.52 +/- 0.04 microm, not significant) or the Hill coefficient (4.75 +/- 0.67 versus 5.02 +/- 1.1, not significant). AS/HNO did not alter myofibrillar Mg-ATPase activity, supporting an effect on the myofilaments themselves. The thiol reducing agent dithiothreitol (DTT, 5.0 mm) both prevented and reversed HNO action, confirming AS/HNO redox sensitivity. Lastly, NO (from DEA/NO) did not mimic AS/HNO cardiac effects. Thus, in addition to reported changes in Ca(2+) cycling, HNO also acts as a cardiac Ca(2+) sensitizer, augmenting maximal force without altering actomyosin ATPase activity. This is likely to be due to modulation of myofilament proteins that harbour reactive thiolate groups that are targets of HNO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331988      PMCID: PMC2075441          DOI: 10.1113/jphysiol.2007.129254

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

Review 1.  Regulation of cardiac beta-adrenergic response by nitric oxide.

Authors:  J L Balligand
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

2.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

3.  Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides.

Authors:  D Sarkar; P Vallance; C Amirmansour; S E Harding
Journal:  Cardiovasc Res       Date:  2000-12       Impact factor: 10.787

4.  The C terminus of cardiac troponin I is essential for full inhibitory activity and Ca2+ sensitivity of rat myofibrils.

Authors:  H M Rarick; X H Tu; R J Solaro; A F Martin
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

5.  Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan.

Authors:  J Levijoki; P Pollesello; J Kaivola; C Tilgmann; T Sorsa; A Annila; I Kilpeläinen; H Haikala
Journal:  J Mol Cell Cardiol       Date:  2000-03       Impact factor: 5.000

6.  Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.

Authors:  F Brunner; P Andrew; G Wölkart; R Zechner; B Mayer
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

7.  Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling.

Authors:  N Paolocci; W F Saavedra; K M Miranda; C Martignani; T Isoda; J M Hare; M G Espey; J M Fukuto; M Feelisch; D A Wink; D A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

8.  Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes.

Authors:  Joanne Layland; Jian-Mei Li; Ajay M Shah
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

9.  Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart.

Authors:  Walter F Saavedra; Nazareno Paolocci; Marcus E St John; Michel W Skaf; Garrick C Stewart; Jin-Sheng Xie; Robert W Harrison; Joshua Zeichner; Daniel Mudrick; Eduardo Marbán; David A Kass; Joshua M Hare
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

10.  cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.

Authors:  N Paolocci; U E Ekelund; T Isoda; M Ozaki; K Vandegaer; D Georgakopoulos; R W Harrison; D A Kass; J M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

View more
  42 in total

1.  Nitroxyl effects on myocardium provide new insights into the significance of altered myofilament response to calcium in the regulation of contractility.

Authors:  R John Solaro
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

Review 2.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

3.  The shy Angeli and his elusive creature: the HNO route to vasodilation.

Authors:  Nazareno Paolocci; David A Wink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 4.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

5.  Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.

Authors:  Guangshuo Zhu; Dieter Groneberg; Gautam Sikka; Daijiro Hori; Mark J Ranek; Taishi Nakamura; Eiki Takimoto; Nazareno Paolocci; Dan E Berkowitz; Andreas Friebe; David A Kass
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

6.  A change of heart: oxidative stress in governing muscle function?

Authors:  Martin Breitkreuz; Nazha Hamdani
Journal:  Biophys Rev       Date:  2015-06-27

Review 7.  Oxidative stress and sarcomeric proteins.

Authors:  Susan F Steinberg
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

8.  Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat.

Authors:  Xiaoxu Shen; Niraj Bhatt; Jianhong Xu; Tao Meng; Miguel A Aon; Brian O'Rourke; Dan E Berkowitz; Sonia Cortassa; Wei Dong Gao
Journal:  J Pharmacol Exp Ther       Date:  2014-01-15       Impact factor: 4.030

9.  Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites.

Authors:  Genaro A Ramirez-Correa; Sonia Cortassa; Brian Stanley; Wei Dong Gao; Anne M Murphy
Journal:  J Mol Cell Cardiol       Date:  2010-01-18       Impact factor: 5.000

Review 10.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.